Skip to content

Freenome

US · FRNM #2882 by market cap Listed 2024
9.36 -0.57 -5.69%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

About Freenome

Freenome Inc is a development-stage, early cancer detection company developing blood-based screening tests leveraging a proprietary artificial intelligence/machine learning multiomics technology platform to transform multi-cancer and ultimately multi-disease detection. It is developing a range of blood-based cancer screening tests.

CEO
Dr. Aaron Elliott, PhD
Fiscal year end
12-31
Website
freenome.com

Company profile

Exchange
US
Symbol
FRNM
Market-cap rank
#2882
Listing date
2024-06-12
Market cap
1.04B
Float cap
465.98M
Shares out
111.50M
Float shares
49.78M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 20:02:17 · For reference only, not investment advice and not tailored to your situation.

Freenome discussion 0 comments

Add a comment